Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations
Hanako Kohama,1 Takeshi Ide,1 Kazuro Ikawa,2 Norifumi Morikawa,2 Shinichi Nishi1 1Division of Intensive Care Unit, Hyogo College of Medicine, Nishinomiya, 2Department of Clinical Pharmacotherapy, Hiroshima University, Hiroshima, Japan Background: Tazobactam/piperacillin (TAZ/PIPC), which is often co...
Saved in:
Main Authors: | Kohama H, Ide T, Ikawa K, Morikawa N, Nishi S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/3f1737d6e2a64a4c9feaf574a2aab771 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SIMULTANEOUS DETERMINATION OF PIPERACILLIN AND TAZOBACTAM IN THE PHARMACEUTICAL FORMULATION TAZONAM® BY DERIVATIVE SPECTROPHOTOMETRY
by: TORAL,M. INÉS, et al.
Published: (2012) -
Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in <named-content content-type="genus-species">Escherichia coli</named-content>
by: Lisa M. Schechter, et al.
Published: (2018) -
Susceptibilidad de enterobacterias a piperacilina/tazobactam en un hospital pediátrico de Chile
by: Vega,Juan Rojas De la, et al.
Published: (2017) -
Concentraciones plasmáticas de piperacilina/tazobactam en pacientes pediátricos críticos sometidos a ECMO. Análisis preliminar
by: Zylbersztajn,Brenda, et al.
Published: (2020) -
Evaluación de la sensibilidad de cepas de Pseudomonas aeruginosa multi-resistentes frente a ceftolozano/tazobactam
by: Prado-Montoro,César Del, et al.
Published: (2019)